RGS12
Regulator of G-protein signaling 12
Also known as: RGS12_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14924
- Gene
- RGS12
- Ensembl
- ENSG00000159788
- Chromosome
- 4
- Canonical length
- 1447 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
This gene encodes a member of the 'regulator of G protein signaling' (RGS) gene family. The encoded protein may function as a guanosine triphosphatase (GTPase)-activating protein as well as a transcriptional repressor. This protein may play a role in tumorigenesis. Multiple transcript variants encoding distinct isoforms have been identified for this gene. Other alternative splice variants have been described but their biological nature has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1447 residues, UniProt reviewed canonical sequence.
>O14924|RGS12
1 MFRAGEASKR PLPGPSPPRV RSVEVARGRA GYGFTLSGQA PCVLSCVMRG SPADFVGLRA
61 GDQILAVNEI NVKKASHEDV VKLIGKCSGV LHMVIAEGVG RFESCSSDEE GGLYEGKGWL
121 KPKLDSKALG INRAERVVEE MQSGGIFNMI FENPSLCASN SEPLKLKQRS LSESAATRFD
181 VGHESINNPN PNMLSKEEIS KVIHDDSVFS IGLESHDDFA LDASILNVAM IVGYLGSIEL
241 PSTSSNLESD SLQAIRGCMR RLRAEQKIHS LVTMKIMHDC VQLSTDKAGV VAEYPAEKLA
301 FSAVCPDDRR FFGLVTMQTN DDGSLAQEEE GALRTSCHVF MVDPDLFNHK IHQGIARRFG
361 FECTADPDTN GCLEFPASSL PVLQFISVLY RDMGELIEGM RARAFLDGDA DAHQNNSTSS
421 NSDSGIGNFH QEEKSNRVLV VDLGGSSSRH GPGGSAWDGV GGRGAQPWGA PWTGPFCPDP
481 EGSPPFEAAH QTDRFWDLNK HLGPASPVEV PPASLRSSVP PSKRGTVGAG CGFNQRWLPV
541 HVLREWQCGH TSDQDSYTDS TDGWSSINCG TLPPPMSKIP ADRYRVEGSF AQPPLNAPKR
601 EWSRKAFGMQ SIFGPHRNVR KTKEDKKGSK FGRGTGLTQP SQRTSARRSF GRSKRFSITR
661 SLDDLESATV SDGELTGADL KDCVSNNSLS SNASLPSVQS CRRLRERRVA SWAVSFERLL
721 QDPVGVRYFS DFLRKEFSEE NILFWQACEY FNHVPAHDKK ELSYRAREIF SKFLCSKATT
781 PVNIDSQAQL ADDVLRAPHP DMFKEQQLQI FNLMKFDSYT RFLKSPLYQE CILAEVEGRA
841 LPDSQQVPSS PASKHSLGSD HSSVSTPKKL SGKSKSGRSL NEELGDEDSE KKRKGAFFSW
901 SRTRSTGRSQ KKREHGDHAD DALHANGGLC RRESQGSVSS AGSLDLSEAC RTLAPEKDKA
961 TKHCCIHLPD GTSCVVAVKA GFSIKDILSG LCERHGINGA AADLFLVGGD KPLVLHQDSS
1021 ILESRDLRLE KRTLFRLDLV PINRSVGLKA KPTKPVTEVL RPVVARYGLD LSGLLVRLSG
1081 EKEPLDLGAP ISSLDGQRVV LEEKDPSRGK ASADKQKGVP VKQNTAVNSS SRNHSATGEE
1141 RTLGKSNSIK IKGENGKNAR DPRLSKREES IAKIGKKKYQ KINLDEAEEF FELISKAQSN
1201 RADDQRGLLR KEDLVLPEFL RLPPGSTELT LPTPAAVAKG FSKRSATGNG RESASQPGEQ
1261 WEPVQESSDS PSTSPGSASS PPGPPGTTPP GQKSPSGPFC TPQSPVSLAQ EGTAQIWKRQ
1321 SQEVEAGGIQ TVEDEHVAEL TLMGEGDISS PNSTLLPPPS TPQEVPGPSR PGSGTHGSRD
1381 LPVNRIIDVD LVTGSAPGRD GGIAGAQAGP GRSQASGGPP TSDLPGLGPV PGEPAKPKTS
1441 AHHATFVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RGS12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 30 nTPM
- cerebral cortex: 27 nTPM
- basal ganglia: 21 nTPM
- amygdala: 21 nTPM
- cerebellum: 20 nTPM
- skin: 20 nTPM
Single-cell type
- ocular epithelial cells: 546 nCPM
- epididymal basal cells: 495 nCPM
- esophageal suprabasal cells: 339 nCPM
- suprabasal keratinocytes: 338 nCPM
- esophageal apical cells: 288 nCPM
- epididymal efferent duct ciliated cells: 238 nCPM
Immune cell
- intermediate monocyte: 1.2 nTPM
- non-classical monocyte: 1.1 nTPM
- myeloid DC: 0.4 nTPM
- basophil: 0.3 nTPM
- classical monocyte: 0.3 nTPM
- naive CD4 T-cell: 0.3 nTPM
Brain region
- cerebral cortex: 102 nTPM
- amygdala: 33 nTPM
- basal ganglia: 32 nTPM
- hippocampal formation: 31 nTPM
- choroid plexus: 28 nTPM
- cerebellum: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RGS12.
Disease | ImmuneIEDB
Conditions an epitope on RGS12 was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.61
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- negative regulation of signal transduction
- regulation of G protein-coupled receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PDZ domain
- GoLoco motif
- Raf-like Ras-binding
- PTB/PI domain
- PH-like domain superfamily
- RGS domain
- RGS, subdomain 1/3
- Ubiquitin-like domain superfamily
- PDZ superfamily
- RGS domain superfamily
- RGS, subdomain 2
- Regulator of G-protein signaling 10/12/14-like
- PDZ domain
- Regulator of G protein signaling domain
- GoLoco motif
- Raf-like Ras-binding domain
- RGS12, RGS domain
- Unstructured region between RBD and GoLoco
- C-terminal unstructured region of RGS12
- Unstructured region of RGS12
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RGS12 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RGS12 as an antibody target. Whether an autoantibody or antibody against RGS12 could matter depends on whether native RGS12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RGS12 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RGS12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...